Product image of Intratect (Human Normal Immunoglobulin) supplied by GNH India

Intratect

Active Ingredient:
Human Normal Immunoglobulin
Origin:
EU

Intratect (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Intratect, is an immunoglobulin (IgG) presented as a sterile solution for intravenous use. It is indicated for immunoglobulin replacement therapy in patients with antibody deficiencies and is used to treat primary or secondary immunodeficiency, Kawasaki disease, and immune‑mediated thrombocytopenia.

GNH India supplies Intratect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide, ensuring quality, regulatory compliance, reliable cold‑chain logistics and dedicated technical support throughout global markets.

Manufacturer / TM Owner

Biotest Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Intratect, an immunoglobulin replacement therapy, is used to restore antibody levels in several immune‑related conditions.

  • Primary immunodeficiency diseases: restores IgG levels to reduce infection frequency.
  • Secondary immunodeficiency (e.g., chemotherapy, HIV): provides passive immunity to support compromised patients.
  • Kawasaki disease: reduces inflammation and prevents coronary artery complications.
  • Idiopathic thrombocytopenic purpura: modulates immune response to increase platelet counts.

How It Works

  • Human Normal Immunoglobulin supplies exogenous IgG antibodies that bind to a broad range of pathogens, neutralize toxins, and facilitate opsonization for phagocytosis. The infused IgG also interacts with Fc receptors on immune cells, modulating cytokine production and down‑regulating auto‑reactive B‑cell activity, thereby providing passive immunity and immune regulation in deficient or dysregulated states.

Side Effects

Intratect may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache: mild to moderate pain in the head.
  • Fever: transient elevation of body temperature.
  • Chills: shaking sensations during or after infusion.
  • Fatigue: general tiredness post‑infusion.
  • Nausea: mild gastrointestinal upset.
  • Infusion‑related reactions: flushing, erythema, or mild hypotension.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate treatment.
  • Thromboembolic events: clot formation in vessels.
  • Acute renal failure: sudden loss of kidney function.
  • Aseptic meningitis: inflammation of meninges without infection.
  • Hemolysis: destruction of red blood cells.
  • Severe hypotension: marked drop in blood pressure.

Precautions & Warnings

Before initiating Intratect therapy, several precautions should be observed to ensure safety.

  • Assess baseline IgG levels: determine need for replacement.
  • Monitor for infusion reactions: observe vital signs during administration.
  • Adjust infusion rate if reactions occur: slow down or pause infusion.
  • Premedicate when indicated: use antihistamines or acetaminophen to reduce reactions.
  • Contraindicate in patients with severe IgA deficiency and anti‑IgA antibodies: risk of anaphylaxis.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Intratect can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid)

  • Live vaccines: may cause uncontrolled infection due to immunosuppression.
  • Concurrent immunoglobulin products: risk of IgG overload.
  • Anticoagulants: increased bleeding risk from volume load.
  • ACE inhibitors: potential for additive hypotension.
  • Immunosuppressants: may diminish intended immune modulation.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: may mask infusion reactions.
  • Diuretics: monitor fluid balance during infusion.
  • Antibiotics with nephrotoxic potential: watch renal function.

Frequently Asked Questions

Intratect is a sterile intravenous solution of human normal immunoglobulin used as immunoglobulin replacement therapy to treat patients with primary or secondary immunodeficiency, Kawasaki disease, and immune thrombocytopenic purpura, providing passive immunity and modulating immune responses.

Human Normal Immunoglobulin supplies a broad spectrum of IgG antibodies that bind pathogens, neutralize toxins, and promote opsonization. The antibodies also interact with Fc receptors, influencing cytokine release and down‑regulating autoreactive immune cells, thereby restoring immune competence in deficient states.

The dosing of Intratect is individualized; the prescribing clinician determines the amount, infusion rate, and frequency based on the patient’s IgG level, weight, clinical condition, and response to therapy. No fixed regimen is provided in the product information.

Safety data for Intratect in pregnancy and lactation are limited. The product should be used only if the potential benefit to the mother outweighs any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To request Intratect, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping options and necessary import documentation.

Intratect is a human normal immunoglobulin preparation similar to other IVIG products, offering comparable IgG content and clinical efficacy. Differences may exist in manufacturing processes, stabilizers, and approved indications, so clinicians consider product‑specific data, availability, and patient tolerance when selecting therapy.

Intratect must be stored refrigerated at 2‑8 °C, protected from light, and kept in the original container. It should not be frozen or shaken; before use, gently swirl to ensure uniformity and inspect for particulates or discoloration.

Intratect is given by intravenous infusion under medical supervision. The infusion rate is started slowly and may be increased as tolerated, with vital signs monitored throughout. Premedication such as acetaminophen or antihistamines may be used to reduce infusion‑related reactions.

Serious adverse events include anaphylaxis, thromboembolic complications, acute renal failure, aseptic meningitis, hemolysis, and severe hypotension. Patients should be closely monitored during and after infusion, and any signs of these reactions require immediate medical attention.

Intratect is contraindicated in individuals with a known severe IgA

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Normal Immunoglobulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT